Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast and Formula Milk and Early Puberty Onset.
Calcaterra V, Cena H, Sottotetti F, Rossi V, Loperfido F, Zuccotti G. Calcaterra V, et al. Among authors: sottotetti f. Children (Basel). 2023 Oct 14;10(10):1686. doi: 10.3390/children10101686. Children (Basel). 2023. PMID: 37892349 Free PMC article. Review.
Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2- metastatic breast cancer: a prospective, monocentric study.
Palumbo R, Quaquarini E, Saltalamacchia G, Malovini A, Lapidari P, Tagliaferri B, Mollica L, Teragni CM, Barletta C, Locati LD, Sottotetti F. Palumbo R, et al. Among authors: sottotetti f. Drugs Context. 2024 Feb 5;13:2023-7-5. doi: 10.7573/dic.2023-7-5. eCollection 2024. Drugs Context. 2024. PMID: 38332945 Free PMC article.
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer.
Chiodoni C, Sangaletti S, Lecchi M, Ciniselli CM, Cancila V, Tripodi I, Ratti C, Talarico G, Brich S, De Cecco L, Baili P, Truffi M, Sottotetti F, Piccotti F, Tripodo C, Pruneri G, Triulzi T, Corsi F, Cappelletti V, Di Cosimo S, Verderio P, Colombo MP. Chiodoni C, et al. Among authors: sottotetti f. ESMO Open. 2023 Aug;8(4):101590. doi: 10.1016/j.esmoop.2023.101590. Epub 2023 Jun 30. ESMO Open. 2023. PMID: 37393630 Free PMC article.
Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2- breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
Tagliaferri B, Mollica L, Palumbo R, Leli C, Malovini A, Terzaghi M, Quaquarini E, Teragni C, Maccarone S, Premoli A, Sottotetti F. Tagliaferri B, et al. Among authors: sottotetti f. Drugs Context. 2023 Jun 20;12:2023-1-7. doi: 10.7573/dic.2023-1-7. eCollection 2023. Drugs Context. 2023. PMID: 37378079 Free PMC article.
The prognostic role of variations in tumour markers (CEA, CA15.3) in patients with metastatic breast cancer treated with CDK4/6 inhibitors.
Sottotetti F, Ferraris E, Tagliaferri B, Palumbo R, Quaquarini E, Teragni C, Balletti E, Leli C, Premoli A, Mollica L, Puglisi S, Sardi S, Malovini A, Pedrazzoli P, Bernardo A. Sottotetti F, et al. Drugs Context. 2022 Sep 5;11:2022-1-3. doi: 10.7573/dic.2022-1-3. eCollection 2022. Drugs Context. 2022. PMID: 36118250 Free PMC article.
44 results